FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891622063> ?p ?o ?g. }

• W2891622063 endingPage "S171" @default.
• W2891622063 startingPage "S171" @default.
• W2891622063 abstract "Lung cancer is the most common cancer and cancer related death amongst male in India. There is paucity of data about AYA lung cancer epidemiology and treatment outcome in India. Here, we have analyzed demography, molecular features and treatment outcome in AYA lung cancer patients treated at our center. This is a single institutional review of patients aged 10 to 35 years treated between Oct’13 and Feb’18 with diagnosis of Lung cancer. Those with diagnosis of squamous cell carcinoma (SCC) and adenocarcinoma were analyzed for demographic feature, clinico-pathological characteristics whereas treatment outcome and survival analysis was done in patients with advanced disease who received treatment. Total 48 patients were registered with median age of 30 years (range: 10-35). Histology was – neuroendocrine tumor in 6 (13%), mucoepidermoid carcinoma in 3 (6%), SCC in 4 (8%) and adenocarcinoma in 35 (73%) patients. Baseline features are outlined in Table 1. Thirty-two (82%) patients had metastasis on diagnosis and 40% (n=10) patients had ALK-rearranged adenocarcinoma. After median follow-up of 9.6 months (range: 1.1-56.2), median progression-free survival (PFS) was 14.4 months (95 CI: 6.2-35) and median overall survival (OS) was 31.6 months (95 CI: 8.2 – not reached). Median PFS was 8.7 months & 35.5 months whereas median OS was 17.9 months & 56.2 months in patients treated with chemotherapy (n=16) and with tyrosine kinase-inhibitor (n=11), respectively. Median PFS was 35.5, 14.4 & 6.2 months whereas median OS was 56.2, not reached & 8.9 months in patients treated with EGFR mutation (n=5), ALK-rearrangement (n=9) and molecular negative (n=11) tumors, respectively. Table 1: Baseline characteristics and treatment details (n=39). Adenocarcinoma was the predominant histology and ALK-rearrangement was very high (40%) in our AYA lung cancer cohort, and majority (82%) had advanced disease on diagnosis. Outcome was excellent with molecular targeted therapy." @default.
• W2891622063 created "2018-09-27" @default.
• W2891622063 creator A5004964411 @default.
• W2891622063 creator A5011415920 @default.
• W2891622063 creator A5025331824 @default.
• W2891622063 creator A5052114605 @default.
• W2891622063 date "2018-09-01" @default.
• W2891622063 modified "2023-10-18" @default.
• W2891622063 title "P26 Lung Cancer in Adolescent & Young Adults: Single Center Experience from Eastern India" @default.
• W2891622063 doi "https://doi.org/10.1016/j.jtho.2018.07.065" @default.
• W2891622063 hasPublicationYear "2018" @default.
• W2891622063 type Work @default.
• W2891622063 sameAs 2891622063 @default.
• W2891622063 citedByCount "0" @default.
• W2891622063 crossrefType "journal-article" @default.
• W2891622063 hasAuthorship W2891622063A5004964411 @default.
• W2891622063 hasAuthorship W2891622063A5011415920 @default.
• W2891622063 hasAuthorship W2891622063A5025331824 @default.
• W2891622063 hasAuthorship W2891622063A5052114605 @default.
• W2891622063 hasBestOaLocation W28916220631 @default.
• W2891622063 hasConcept C121608353 @default.
• W2891622063 hasConcept C126322002 @default.
• W2891622063 hasConcept C143998085 @default.
• W2891622063 hasConcept C2776256026 @default.
• W2891622063 hasConcept C2779292878 @default.
• W2891622063 hasConcept C2781182431 @default.
• W2891622063 hasConcept C71924100 @default.
• W2891622063 hasConcept C90924648 @default.
• W2891622063 hasConceptScore W2891622063C121608353 @default.
• W2891622063 hasConceptScore W2891622063C126322002 @default.
• W2891622063 hasConceptScore W2891622063C143998085 @default.
• W2891622063 hasConceptScore W2891622063C2776256026 @default.
• W2891622063 hasConceptScore W2891622063C2779292878 @default.
• W2891622063 hasConceptScore W2891622063C2781182431 @default.
• W2891622063 hasConceptScore W2891622063C71924100 @default.
• W2891622063 hasConceptScore W2891622063C90924648 @default.
• W2891622063 hasIssue "9" @default.
• W2891622063 hasLocation W28916220631 @default.
• W2891622063 hasOpenAccess W2891622063 @default.
• W2891622063 hasPrimaryLocation W28916220631 @default.
• W2891622063 hasRelatedWork W2024818960 @default.
• W2891622063 hasRelatedWork W2040381674 @default.
• W2891622063 hasRelatedWork W2308954949 @default.
• W2891622063 hasRelatedWork W2319099512 @default.
• W2891622063 hasRelatedWork W2363201698 @default.
• W2891622063 hasRelatedWork W2376684597 @default.
• W2891622063 hasRelatedWork W2394427899 @default.
• W2891622063 hasRelatedWork W2403361534 @default.
• W2891622063 hasRelatedWork W3171615116 @default.
• W2891622063 hasRelatedWork W4200188553 @default.
• W2891622063 hasVolume "13" @default.
• W2891622063 isParatext "false" @default.
• W2891622063 isRetracted "false" @default.
• W2891622063 magId "2891622063" @default.
• W2891622063 workType "article" @default.